Skip to main content
. 2021 Sep 23;17(9):e1009871. doi: 10.1371/journal.ppat.1009871

Table 2. Drug resistance mutations in CSF.

PID VL (copies/ml)
Pl/CSF
Drug resistance mutation TFV (ng/ml)
Pl/CSF
FTC (ng/ml)
Pl/CSF
EFV (ng/ml)
Pl/CSF
LPV (ng/ml)
Pl/CSF
RTV (ng/ml)
Pl/CSF
0161 <40/1350 None detected 76/3.0 445/256 1490/4.4 3.0/3.0 3.0/3.0
0213 <40/1330 V82A/D67N/K70E/L74I/V106M/M184V/G190A 225/4.9 420/153 3.0/3.0 7730/7.0 935/3.0
0189 12802/310 K65R/V75I/M184V/L100I/K103N/P225H 82/3.0 146/175 1990/9.6 3.0/3.0 3.0/3.0
0133 19551/28250 M46I/V82A/D67N/K70R/M184V/T215F/K103N/K238T 19/5.0 63/71 3.0/3.0 14/3.0 3.0/3.0
0183 58000/1300 D67N/M184V/K103N/V106M 55/3.0 229/129 2460/3.0 3.0/3.0 3.0/3.0
0140 254/21370 K101E 33/3.0 98/123 5530/40 3.0/3.0 3.0/3.0
0164 620/2900 K101E 43/3.0 518/169 4130/8.8 3.0/3.0 3.0/3.0
0168 936/3030 None detected 56/3.0 286/196 2370/3.5 3.0/3.0 3.0/3.0
0172 24000/801 None detected 3.0/3.0 3.0/3.0 3.8/3.0 3.0/3.0 3.0/3.0

PID: participant ID. Pl: plasma. LPV: lopinavir. RTV: ritonavir. Limit of detection 40 copies/mL for VL and 3.0 ng/mL for antiretroviral drugs.